These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 1995881)

  • 41. Oxazaphosphorines combined with immune checkpoint blockers: dose-dependent tuning between immune and cytotoxic effects.
    Delahousse J; Skarbek C; Desbois M; Perfettini JL; Chaput N; Paci A
    J Immunother Cancer; 2020 Aug; 8(2):. PubMed ID: 32784216
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Peptide conjugates of 4-aminocyclophosphamide as prodrugs of phosphoramide mustard for selective activation by prostate-specific antigen (PSA).
    Jiang Y; Hu L
    Bioorg Med Chem; 2013 Dec; 21(23):7507-14. PubMed ID: 24139844
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cross-linking of DNA in L1210 cells and nuclei treated with cyclophosphamide and phosphoramide mustard.
    Surya YA; Rosenfeld JM; Hillcoat BL
    Cancer Treat Rep; 1978 Jan; 62(1):23-9. PubMed ID: 564237
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Phase 1 study of the safety, tolerability, and pharmacokinetics of TH-302, a hypoxia-activated prodrug, in patients with advanced solid malignancies.
    Weiss GJ; Infante JR; Chiorean EG; Borad MJ; Bendell JC; Molina JR; Tibes R; Ramanathan RK; Lewandowski K; Jones SF; Lacouture ME; Langmuir VK; Lee H; Kroll S; Burris HA
    Clin Cancer Res; 2011 May; 17(9):2997-3004. PubMed ID: 21415214
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cyclophosphamide modulates rat hepatic cytochrome P450 2C11 and steroid 5 alpha-reductase activity and messenger RNA levels through the combined action of acrolein and phosphoramide mustard.
    Chang TK; Waxman DJ
    Cancer Res; 1993 Jun; 53(11):2490-7. PubMed ID: 8495410
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Stabilities of 7-alkylguanosines and 7-deoxyguanosines formed by phosphoramide mustard and nitrogen mustard.
    Kallama S; Hemminki K
    Chem Biol Interact; 1986 Jan; 57(1):85-96. PubMed ID: 3948286
    [TBL] [Abstract][Full Text] [Related]  

  • 47. 2',3'-Bis(2-chloroethyl)aminophosphoryl-3'-amino-3'-deoxyadenosine: a cyclic nucleotide with antitumor activity.
    Okruszek A; Verkade JG
    J Med Chem; 1979 Jul; 22(7):882-5. PubMed ID: 448687
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Nucleoside conjugates. 10. Synthesis and antitumor activity of 1-beta-D-arabinofuranosylcytosine 5'-diphosphate-1,2-dipalmitins.
    Hong CI; An SH; Schliselfeld L; Buchheit DJ; Nechaev A; Kirisits AJ; West CR
    J Med Chem; 1988 Sep; 31(9):1793-8. PubMed ID: 3411602
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Synthesis and evaluation of sulfonylethyl-containing phosphotriesters of 3'-azido-3'-deoxythymidine as anticancer prodrugs.
    Wang J; Wang YJ; Chen ZS; Kwon CH
    Bioorg Med Chem; 2014 Nov; 22(21):5747-56. PubMed ID: 25440502
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Kinetics of phosphoramide mustard hydrolysis in aqueous solution.
    Watson E; Dea P; Chan KK
    J Pharm Sci; 1985 Dec; 74(12):1283-92. PubMed ID: 4087195
    [TBL] [Abstract][Full Text] [Related]  

  • 51. An improved synthesis of lysosomal activated mustard prodrug for tumor-specific activation and its cytotoxic evaluation.
    Adidala R; Devalapally H; Srivari C; Devarakonda R K; Akkinepally RR
    Drug Dev Ind Pharm; 2012 Sep; 38(9):1047-53. PubMed ID: 22185667
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Synthesis and study of a spin-labeled cyclophosphamide analogue, 3-(1-oxy-2,2,6,6-tetramethyl-4-piperidinyl)cyclophosphamide.
    Tsui FP; Robey FA; Engle TW; Ludeman SM; Zon G
    J Med Chem; 1982 Sep; 25(9):1106-10. PubMed ID: 7131492
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Synthesis and structure-activity relationships of pre-activated analogs of cyclophosphamide (NSC-26271).
    Montgomery JA; Struck RF
    Cancer Treat Rep; 1976 Apr; 60(4):381-93. PubMed ID: 945126
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Synthesis and antitumor activity of 6-trifluoromethylcyclophosphamide and related compounds.
    Farmer PB; Cox PJ
    J Med Chem; 1975 Nov; 18(11):1106-10. PubMed ID: 1177256
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Half-life of oxazaphosphorines in biological fluids.
    Sladek NE; Powers JF; Grage GM
    Drug Metab Dispos; 1984; 12(5):553-9. PubMed ID: 6149904
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effects of phosphoramide mustard and acrolein, cytotoxic metabolites of cyclophosphamide, on mouse limb development in vitro.
    Hales BF
    Teratology; 1989 Jul; 40(1):11-20. PubMed ID: 2763206
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Synthesis, hydrolytic reactivity, and anticancer evaluation of N- and O-triorganosilylated compounds as new types of potential prodrugs.
    Chiu FT; Chang YH; Ozkan G; Zon G; Fichter KC; Phillips LR
    J Pharm Sci; 1982 May; 71(5):542-51. PubMed ID: 7097502
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Synthesis of phosphoramide mustard analogues of daunomycin and carminomycin.
    Csorvási A; Kövér KE; Menyhárt MM; Sztaricskai F; Dobrynin YV; Nikolaeva TG
    Arch Pharm (Weinheim); 1998 Sep; 331(9):265-8. PubMed ID: 9793480
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Anticancer activity of stabilized palifosfamide in vivo: schedule effects, oral bioavailability, and enhanced activity with docetaxel and doxorubicin.
    Jones B; Komarnitsky P; Miller GT; Amedio J; Wallner BP
    Anticancer Drugs; 2012 Feb; 23(2):173-84. PubMed ID: 22027537
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Novel Sophoridine Derivatives Bearing Phosphoramide Mustard Moiety Exhibit Potent Antitumor Activities In Vitro and In Vivo.
    Li D; Dai L; Zhao X; Zhi S; Shen H; Yang Z
    Molecules; 2018 Aug; 23(8):. PubMed ID: 30082625
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.